• Skip to primary navigation
  • Skip to main content
  • Skip to primary sidebar
  • Skip to footer
  • Advertise
  • Subscribe

MassDevice

The Medical Device Business Journal — Medical Device News & Articles | MassDevice

  • Latest News
  • Technologies
    • Artificial Intelligence (AI)
    • Cardiovascular
    • Orthopedics
    • Neurological
    • Diabetes
    • Surgical Robotics
  • Business & Finance
    • Wall Street Beat
    • Earnings Reports
    • Funding Roundup
    • Mergers & Acquisitions
    • Initial Public Offering (IPO)
    • Legal News
    • Personnel Moves
    • Medtech 100 Stock Index
  • Regulatory & Compliance
    • Food & Drug Administration (FDA)
    • Recalls
    • 510(k)
    • Pre-Market Approval (PMA)
    • MDSAP
    • Clinical Trials
  • Special Content
    • Special Reports
    • In-Depth Coverage
    • DeviceTalks
  • Podcasts
    • MassDevice Fast Five
    • DeviceTalks Weekly
    • OEM Talks
      • AbbottTalks
      • Boston ScientificTalks
      • DeviceTalks AI
      • IntuitiveTalks
      • MedtechWOMEN Talks
      • MedtronicTalks
      • Neuro Innovation Talks
      • Ortho Innovation Talks
      • Structural Heart Talks
      • StrykerTalks
  • Resources
    • About MassDevice
    • DeviceTalks
    • Newsletter Signup
    • Leadership in Medtech
    • Manufacturers & Suppliers Search
    • MedTech100 Index
    • Videos
    • Webinars
    • Whitepapers
    • Voices
Home » BD voluntarily recalls intraosseous products

BD voluntarily recalls intraosseous products

June 23, 2022 By Sean Whooley

BD Becton Dickinson logoBD (NYSE:BDX) announced that it issued a voluntary recall for select lots of a trio of its intraosseous products.

Franklin Lakes, New Jersey-based BD’s recall covers its Intraosseous Needle Set Kits, Intraosseous Manual Driver Kits and Intraosseous Powered Drivers.

According to a news release, certain lots within the expiration date of the affected products may result in a series of potential issues. There may be difficulty separating the stylet from the intraosseous needle where the increased force required to remove the stylet from the intraosseous needle results in inadvertent removal of the entire needle assembly during placement or the inability to remove the stylet from an indwelling intraosseous needle, both resulting in the functional loss of intraosseous access.

Additionally, users may experience an issue in which the needle safety mechanism on the stylet does not deploy after the placement of the intraosseous needle and removal of the stylet from the needle. Metal discs intended to connect the needle assembly to the magnet in the powered driver may also stick unexpectedly to the magnet, rendering the driver unusable.

The issues affecting the needle kits and driver kits may result in delays in care due to limited or non-functioning intraosseous access or could also result in needlestick injuries.

These issues may result in delays in care due to limited or non-functioning intraosseous access or could also lead to needlestick injuries.

BD instructed customers to immediately review inventory for the catalog and lot numbers listed in the recall notice. Affected needle kits should be destroyed in compliance with the healthcare institution’s process for disposal.

Use of affected intraosseous powered drivers should be paused until a BD representative provides instruction that it is safe for use. The company said its representatives will be contacting customers for inspection and will repair the devices if required.

No replacement products currently exist, so BD recommends that customers evaluate their clinical needs and consider obtaining and using an alternative intraosseous product. The company will notify customers when replacement products are made available.

Filed Under: Featured, News Well, Orthopedics, Recalls, Regulatory/Compliance Tagged With: BD

More recent news

  • Presidio wins FDA IDE for ultra-low frequency neuromod, hires new CFO
  • Epiminder study backs implantable EEG tech
  • Neurent Medical wins FDA nod for next-gen chronic rhinitis treatment
  • Medtronic unveils “MiniMed” as name for soon-to-be separated Diabetes unit
  • Medtronic issues safety notice for Hugo surgical robot console in Europe

About Sean Whooley

Sean Whooley is an associate editor who mainly produces work for MassDevice, Medical Design & Outsourcing and Drug Delivery Business News. He received a bachelor's degree in multiplatform journalism from the University of Maryland, College Park. You can connect with him on LinkedIn or email him at [email protected].

Primary Sidebar

“md
EXPAND YOUR KNOWLEDGE AND STAY CONNECTED
Get the latest med device regulatory, business and technology news.

DeviceTalks Weekly

See More >

MEDTECH 100 Stock INDEX

Medtech 100 logo
Market Summary > Current Price
The MedTech 100 is a financial index calculated using the BIG100 companies covered in Medical Design and Outsourcing.
MDO ad

Footer

MASSDEVICE MEDICAL NETWORK

DeviceTalks
Drug Delivery Business News
Medical Design & Outsourcing
Medical Tubing + Extrusion
Drug Discovery & Development
Pharmaceutical Processing World
MedTech 100 Index
R&D World
Medical Design Sourcing

DeviceTalks Webinars, Podcasts, & Discussions

Attend our Monthly Webinars
Listen to our Weekly Podcasts
Join our DeviceTalks Tuesdays Discussion

MASSDEVICE

Subscribe to MassDevice E-Newsletter
Advertise with us
About
Contact us

Copyright © 2025 · WTWH Media LLC and its licensors. All rights reserved.
The material on this site may not be reproduced, distributed, transmitted, cached or otherwise used, except with the prior written permission of WTWH Media.

Privacy Policy